Medicure Inc. Files 6-K with Financial Results
Ticker: MCUJF · Form: 6-K · Filed: Apr 8, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Apr 8, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, sec-filing, foreign-private-issuer
TL;DR
Medicure Inc. dropped their latest financials via a 6-K filing. Check it out.
AI Summary
On April 8, 2024, Medicure Inc. filed a Form 6-K report with the SEC. This report includes a news release detailing their financial results for the period ending in April 2024. The filing confirms Medicure Inc. is a foreign private issuer and will file annual reports under Form 20-F.
Why It Matters
This filing provides investors with updated financial information for Medicure Inc., allowing them to assess the company's performance and make informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial results and does not contain significant new risks.
Key Players & Entities
- Medicure Inc. (company) — Registrant
- Dr. Albert D. Friesen (person) — CEO
- 001-31995 (company) — SEC File Number
- 20240408 (date) — Filing Date
FAQ
What type of report did Medicure Inc. file?
Medicure Inc. filed a Form 6-K report.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report financial results for the month of April 2024 and to confirm Medicure Inc. is a foreign private issuer filing under Form 20-F.
Who signed the report on behalf of Medicure Inc.?
Dr. Albert D. Friesen, CEO, signed the report.
What is Medicure Inc.'s principal executive office address?
The address is 2-1250 Waverley Street, Winnipeg, MB, Canada R3T 6C6.
What is Medicure Inc.'s SIC code?
Medicure Inc.'s SIC code is 2834 for Pharmaceutical Preparations.
Filing Stats: 142 words · 1 min read · ~1 pages · Grade level 8.3 · Accepted 2024-04-08 17:16:24
Filing Documents
- med_6k.htm (6-K) — 8KB
- med_ex991.htm (EX-99.1) — 180KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-24-004368.txt ( ) — 194KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3